When you search "is ketamine FDA approved," the results can be confusing. Some sources say yes. Others say no. Headlines about the FDA ketamine warning add another layer of uncertainty. If you are considering ketamine therapy for depression or chronic pain, you deserve clear, honest answers rather than clickbait.

We want to walk through the facts carefully. The regulatory picture around ketamine is more nuanced than a simple yes or no, and understanding the details can help you make an informed decision about your care.

Is Ketamine FDA Approved?

The short answer is yes, with important context. Ketamine was approved by the FDA in 1970 as an anesthetic. It has been used safely in operating rooms, emergency departments, and field hospitals for over five decades. The World Health Organization includes it on its List of Essential Medicines, recognizing it as one of the safest and most effective medications available globally.

When clinicians use ketamine at lower doses to treat depression, anxiety, PTSD, or chronic pain, that use is considered off-label. This means the FDA has not specifically approved ketamine for those conditions, even though the medication itself has been FDA approved for decades.

There is one important exception. In 2019, the FDA approved Spravato (esketamine), a nasal spray derived from a component of ketamine, specifically for treatment-resistant depression. Spravato must be administered in a certified healthcare setting under observation, similar to how we approach IV ketamine at our clinic.

So when someone asks "is ketamine FDA approved," the most accurate answer is: the medication itself has been FDA approved since 1970. Its use for mental health and pain conditions is off-label, which brings us to an important question.

What Is Off-Label Prescribing?

Off-label prescribing is when a physician or licensed provider prescribes an FDA-approved medication for a condition, dosage, or patient population not specifically listed on its FDA label. This might sound unusual, but it is one of the most common practices in medicine.

Research suggests that roughly one in five prescriptions written in the United States is off-label. Many medications you may have taken were likely prescribed off-label at some point. Some widely recognized examples include:

Off-label use is legal, ethical, and supported by medical literature. The FDA itself has acknowledged that off-label prescribing is a necessary and valuable part of medical practice, particularly when peer-reviewed research supports the use. In the case of ketamine for depression, there are now hundreds of published studies and clinical trials documenting its effects.

For more on how we approach these conversations with patients, visit our frequently asked questions page.

What Did the FDA's 2024 Warning Letter Say?

In 2024, the FDA issued a safety communication that received significant media attention. We believe it is important to address this directly, because the coverage often left out critical context.

The warning focused on compounded ketamine products — specifically, ketamine formulations prepared by compounding pharmacies and dispensed for patients to use at home, often as lozenges, nasal sprays, or sublingual tablets. The FDA raised several concerns:

What the warning did not say is equally important. The FDA did not discourage the use of ketamine in clinical settings under direct medical supervision. The communication did not address IV ketamine infusions administered by licensed providers in monitored environments. It was specifically targeted at the growing trend of telehealth companies prescribing compounded ketamine for unsupervised home use.

We share this not to dismiss the FDA's concerns, which we take seriously, but to help patients distinguish between very different models of care. The risks associated with unsupervised at-home ketamine use are real. The clinical model we follow at Music City Ketamine is fundamentally different.

How Is Clinical IV Ketamine Different from At-Home Ketamine?

The differences between receiving ketamine in a clinical setting and taking it at home are substantial. They affect safety, efficacy, and the overall quality of the therapeutic experience.

Medical supervision. At Music City Ketamine, every infusion is administered and monitored by Marla Peterson, CRNA, who has over 20 years of anesthesia experience. Your vital signs, including heart rate, blood pressure, and oxygen saturation, are tracked continuously. Marla can adjust the infusion rate in real time based on how you are responding. If any concern arises, she is right there to address it immediately. At-home ketamine offers none of this.

Precise dosing. IV delivery allows for exact control over how much medication enters your system and at what rate. The dose can be titrated up or down during the session based on your response. With oral or sublingual formulations used at home, absorption varies widely depending on factors like stomach contents, metabolism, and how long the tablet is held under the tongue. Research suggests that oral bioavailability of ketamine is only about 20 to 25 percent, compared to nearly 100 percent with IV administration.

Highest bioavailability. Because IV ketamine enters the bloodstream directly, virtually all of the medication reaches the brain. This means lower total doses can achieve therapeutic effects, reducing the overall medication load on your body while delivering more consistent results.

Immediate response capability. In the unlikely event of an adverse reaction, a CRNA has the training and equipment to respond within seconds. This level of safety is simply not available in a home setting. Marla's background in anesthesia means she is trained for exactly these situations, even though they are rare.

Controlled environment. Our private treatment suites are designed to support the therapeutic experience. Calm lighting, weighted blankets, noise-canceling headphones, and a quiet space free from the distractions and unpredictability of a home environment all contribute to better outcomes.

To learn more about the clinical team behind your care, read our article on what a CRNA is and why it matters.

How Does Music City Ketamine Comply with Safety Standards?

We hold ourselves to a standard of care that goes beyond what is required, because we believe patients considering ketamine therapy deserve that level of diligence. Here is how our practice operates:

Patient safety is not a policy we follow. It is the foundation of everything we do. When people ask about the FDA warning, we welcome the conversation, because it gives us an opportunity to explain why clinical supervision matters so much. — Marla Peterson, CRNA, Music City Ketamine

For a deeper look at the safety of ketamine therapy in a clinical setting, read our article on whether ketamine therapy is safe.